# Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pathologic-features-of-response-to-neoadjuvant-anti-pd-1-in-resected-non-small/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tricia R. Cottrell,Elizabeth D. Thompson,Patrick M. Forde,Julie E. Stein,Amy S. Duffield,Valsamo Anagnostou,Natasha Rekhtman,Robert A. Anders,Jonathan D. Cuda,Peter B. Illei,E Gabrielson,Frederic B. Askin,Noushin Niknafs,Kellie N. Smith,Moises J. Velez,Jennifer L. Sauter,James M. Isbell,David R. Jones,Richard J. Battafarano,Stephen C. Yang,L. Danilova,Jedd D. Wolchok,Suzanne L. Topalian,Victor E. Velculescu,Drew M. Pardoll,Julie R. Brahmer,Matthew D. Hellmann,Jamie E. Chaft,Ashley Cimino‐Mathews,Janis M. Taube |
| Citations | 603 |
| DOI | 10.1093/annonc/mdy218 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.annalsofoncology.org/article/S0923753419341341/pdf |
| OpenAlex ID | https://openalex.org/W2867613812 |
| PMID | 29982279 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Julie R. Brahmer](https://scholariq.org/researchers/julie-r-brahmer/)
- [Matthew D. Hellmann](https://scholariq.org/researchers/matthew-d-hellmann/)
- [Peter B. Illei](https://scholariq.org/researchers/peter-b-illei/)
- [Frederic B. Askin](https://scholariq.org/researchers/frederic-b-askin/)
- [Patrick M. Forde](https://scholariq.org/researchers/patrick-m-forde/)
- [Natasha Rekhtman](https://scholariq.org/researchers/natasha-rekhtman/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Paper topics

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Inflammatory Biomarkers in Disease Prognosis](https://scholariq.org/topics/inflammatory-biomarkers-in-disease-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.